Back to Resource Center

Skip to the main content.
Let's Connect
Let's Connect

Enteric Hyperoxaluria

PHASE 1A/B

Case Studies

Here you can edit the background of the section

Key Takeaways

The client was struggling to enroll a clinical trial evaluating an investigational therapy for enteric hyperoxaluria in patients who had previously undergone Roux-en-Y bariatric surgery — a common cause of the condition.

The challenge: patients are not often aware they have enteric hyperoxaluria and don’t know it is associated with painful and recurring kidney stones. So, then, how do you interest and enroll patients in a clinical trial?

Drawing on in-depth research and prior experience recruiting patients with kidney stones, BBK Worldwide leveraged a bold strategy that prioritized the very real aspect of kidney stones. 

CASE-STUDY__Enteric-Hyperoxaluria_Image2

__BBK-WEBSITE-ICONS-40-1

We made the connection between bariatric surgery and kidney stones clear for patients, creating awareness and interest in the study — ultimately generating over 300 referrals.

Challenges 

  • Many patients are not aware of enteric hyperoxaluria and its relationship to bariatric surgery and kidney stones.

  • Because levels of oxalate in the kidneys fluctuate, many patients may initially prequalify for the study, only to fail the screening hours later.

 

CASE-STUDY__Enteric-Hyperoxaluria_Image3

 

 

 

 

Solutions and Impact

We cast a large net by targeting those who have had bariatric surgery and kidney stones. We leveraged Facebook videos and static ads, Google Search Engine Marketing (SEM) ads and clinical study postings to position the study as a potential way to treat kidney stones. We also emphasized the option of remote participation, which our research determined would be appealing to the target audience.

 

 

 

Dynamic referral processing was critical to the response, as was collaboration with the clinical research organization to ensure that referrals were contacted while interest was high. The effective combination of tactics and messaging resulted in 20 enrolled patients within a four-month period.

  • Participants_ICON 20 ENROLLED PATIENTS

  • Sites_ICON 9 SITES

  • Countries-ICON-1 1 COUNTRY (US)

  • Calendar_ICON 4 MONTHS OF SUPPORT

Download the PDF version of this case study today:

X

Subscribe to stay connected

Share this page:

Related Resources

Familial Amyloid Polyneuropathy — Neurology and Gene Therapy — Phase 3

case-studies-icon Case Studies

March 23, 2023

Pediatric Spinal Muscular Atrophy — Neurology and Rare Disease — Phase 2

case-studies-icon Case Studies

March 23, 2023

Major Depressive Disorder — Mental Health — Pivotal Phase 3 Study

case-studies-icon Case Studies

March 23, 2023

Back to Resource Center

BBK Worldwide, LLC
117 Kendrick St., Suite 600
Needham, MA 02494 United States

        Terms & Conditions  Privacy Policy

        © 2023 BBK Worldwide. BBK Worldwide is a Publicis Health company.

        Facebook LinkedIn YouTube
        Facebook LinkedIn YouTube

        Terms & Conditions  Privacy Policy

        © 2023 BBK Worldwide. BBK Worldwide is a Publicis Health company.